CSIMarket
 



Cel sci Corporation  (CVM)
Other Ticker:  
 
 



 

What are Cel Sci's Business Segments?



CEL-SCI Corporation is a biotechnology company that specializes in the development of immunotherapy products for the treatment of various diseases, including cancer and infectious diseases. The company's primary focus is on its lead product candidate, Multikine, which is a potential immunotherapy treatment for head and neck cancer.

Segments:
1. Multikine Segment: This segment comprises the development and potential commercialization of the company's lead product candidate, Multikine. Multikine is a candidate for the treatment of head and neck cancer and is currently in advanced stages of clinical trials.

Products:
1. Multikine: Multikine is a unique immunotherapy treatment being developed by CEL-SCI. It is an investigational product that is administered as an adjuvant therapy prior to standard treatment for head and neck cancer. Multikine aims to stimulate the body's immune system to recognize and kill cancer cells, potentially improving patient outcomes.

Services:
1. Clinical Trials: CEL-SCI offers clinical trial services to evaluate the safety and efficacy of its product candidates. This includes conducting Phase I, II, and III clinical trials, which are required to obtain regulatory approvals for the commercialization of their drugs.

2. Research and Development: The company invests significant resources into research and development activities to advance its product pipeline. This includes preclinical studies, formulation development, and manufacturing process optimization.

3. Intellectual Property: CEL-SCI places a strong emphasis on protecting its intellectual property rights. The company actively seeks and maintains patents for its product candidates and technologies to safeguard its inventions from potential competitors.

4. Regulatory Affairs: CEL-SCI has a dedicated team of experts in regulatory affairs who navigate the complex regulatory landscape to ensure compliance with applicable laws and regulations in the jurisdictions where it operates. They work closely with regulatory agencies to obtain regulatory approvals for their products.

5. Manufacturing and Supply Chain: The company has expertise in manufacturing and supply chain management to ensure the efficient and timely production of its product candidates. This includes overseeing the sourcing of raw materials, manufacturing process optimization, quality control, and coordination of distribution to clinical trial sites.

In summary, CEL-SCI Corporation offers a comprehensive range of segments, products, and services focused on the development and potential commercialization of immunotherapy products, with Multikine being the company's primary focus. Their offerings include clinical trial services, research and development, intellectual property protection, regulatory affairs, and manufacturing and supply chain management.
   

Cel Sci Tax Rate Companies within the Biotechnology & Pharmaceuticals Industry



To get more information on Cel Sci's segment. Select each division with the arrow.


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com